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 Nonampullary Duodenal Adenomas Rarely Recur 
after Complete Endoscopic Resection: A Swiss 
Experience Including a Literature Review 
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sociated with large polyp size ( p = 0.003) and lack of endo-
scopic prophylaxis ( p = 0.0008). Delayed post-polypectomy 
bleeding showed a trend in the occurrence of large polyps 
( p = 0.064), and was statistically significantly associated with 
familial cancer syndrome ( p = 0.019) and advanced histopa-
thology ( p = 0.013).  Conclusion: Our data suggest that endo-
scopic polypectomy of NAD is well feasible with high success 
rates. Procedural and delayed hemorrhage seems to be the 
primary issue rather than adenoma recurrence. We therefore 
advocate referral of patients with large NAD to experienced 
centers for endoscopic resection.  © 2017 S. Karger AG, Basel 
 Introduction 
 Duodenal adenomas are rare and mostly coincidental 
findings in patients presenting for routine upper gastro-
intestinal endoscopy. They can be divided into 3 sub-
groups: sporadically occurring duodenal adenomas or 
nonampullary adenomas of the duodenum (NAD), duo-
denal adenomas of the papilla of Vater, and duodenal ad-
enomas associated with genetic polyposis syndromes 
such as familial adenomatous polyposis (FAP) or Peutz-
Jeghers. Since duodenal adenomas bear a risk of malig-
nant transformation comparable to colonic adenomas, 
removal is recommended upon diagnosis  [1] . Due to the 
relatively low incidence of duodenal compared to colonic 
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 Abstract 
 Introduction: Duodenal polyps and especially duodenal ad-
enomas are a rare and mostly coincidental finding in pa-
tients undergoing upper gastrointestinal endoscopy. Due to 
their malignant potential, duodenal adenomas should be re-
moved upon diagnosis. So far, the limited available data on 
the performance of endoscopic polypectomy show conflict-
ing results with regard to adverse events and the adenoma 
recurrence rate.  Patients and Methods: After summarizing 
the currently available data, we retrospectively analyzed all 
patients undergoing endoscopic resection of nonampullary 
duodenal adenomas (NAD) at our institution between 2006 
and 2016.  Results: A total of 78 patients underwent endo-
scopic polypectomy for NAD adenoma. End-of-treatment 
success with complete resection requiring a mean of 1.2 in-
terventions was achieved in 91% ( n = 71). Procedural hemor-
rhage occurred in 12.8% ( n = 10), whereas delayed bleeding 
was noted in 9% ( n = 7). Duodenal perforation was registered 
and successfully treated in 2 cases (2.6%). No adenoma re-
currence was noted following primary complete adenoma 
resection after a mean follow-up time of 33 months. Acute 
post-polypectomy bleeding was statistically significantly as-
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adenoma, large mortality studies are lacking. Until re-
cently, the management of duodenal adenomas consisted 
of local or radical surgical resection, which carries a high 
morbidity and mortality risk as well a high recurrence 
rate. Recently, thanks to refined endoscopic techniques 
such as endoscopic mucosal resection (EMR), minimally 
invasive endoscopic management of such lesions has be-
come the therapeutic approach of choice. Comparable to 
EMR in the right-sided colon, duodenal polypectomy is 
performed after lifting the lesion with submucosal liquid 
injection in order to counteract perforation of the thin 
duodenal wall. Different alternative resection techniques 
such as hybrid endoscopic submucosal dissection  [2] , 
cap-assisted suck and cut  [3] , underwater EMR  [4], and 
band and slough  [5] have been reported in small popula-
tions so far. In addition, remnants of adenomatous tissue 
after primary endoscopic resection may be removed by 
ablative interventions such as argon plasma coagulation 
(APC), radio frequency ablation (RFA), or electrocautery 
 [6] .
 Data currently available on the endoscopic manage-
ment of duodenal adenomas and its adverse events re-
main  limited. Especially, the rates of adverse events and 
adenoma recurrence after polypectomy are very heteroge-
neous among the few available publications. Recently, the 
 American Society of Gastrointestinal Endoscopy has re-
leased their guidelines on the role of endoscopy in duode-
nal adenomas  [7] . We here present a literature overview on 
the available literature and we analyzed the data of all pa-
tients ( n = 78) who underwent EMR for duodenal adeno-
ma at our institution between 2006 and 2016. The purpose 
of this study was to evaluate the efficacy and safety of EMR 
for NAD. We specifically evaluated the rate and risk factors 
of short-term (mainly bleeding and perforation) and long-
term (bleeding) adverse events as well as the frequency of 
adenoma recurrence and the need for follow-up.
 Materials and Methods 
 Patients 
 The primary endpoint of our study was to examine the out-
come of EMR of duodenal polyps with regards to short-term 
 (duodenal perforation, bleeding) and long-term (bleeding) ad-
verse events as well as the frequency of adenoma recurrence. For 
this reason, we reviewed our endoscopic charts from 2006 to 2016. 
Seventy-eight patients ( Fig. 1 ) met the inclusion criteria (patients 
with nonampullary duodenal polyp(s) undergoing endoscopic 
adenoma resection at our institution). Both sporadically occur-
ring duodenal adenomas as well as adenomas in the context of 
 Fig. 1. Patient intervention and follow-up flowchart. 
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FAP were included. All patients gave their written consent to the 
procedure and use of their medical records for research purposes. 
The study was approved by the local Ethics Committee (KEK ZH 
2014-0465). 
 Endoscopies and EMR 
 All esophagogastroduodenoscopies were performed by 3 ex-
perienced endoscopists under non-anesthetist application of pro-
pofol using flexible standard Olympus ® endoscopes. If possible, 
all anticoagulant or antithrombotic medications were discontin-
ued 7 days prior to the intervention. After careful assessment of 
location, size, spreading, and involvement of the major papilla 
(side-viewing endoscope), adenoma resection was conducted us-
ing either a biopsy forceps or snare polypectomy with prior sub-
mucosal isotonic saline injection (NaCl 0.9%) without or with 
blue dye. If technically feasible, en bloc EMR was always aimed 
for. Snare resection was the preferred polypectomy technique 
( Fig. 2 ). In case of residual adenoma tissue on the resection mar-
gins, APC or RFA was conducted. Intravenous butylscopolamine 
was administered at the discretion of the endoscopist. Duodenal 
hemorrhage provoked by polypectomy were subdivided into “mi-
nor” (hemoglobin drop <2 g/L) and “major” (hemoglobin drop 
>2 g/L and/or need for red blood cell transfusion) bleeding. We 
differentiated between immediate (during the polypectomy) or 
delayed bleeding (a second esophagogastroduodenoscopies was 
necessary in the follow-up during the first 2 weeks after polypec-
tomy). If required, endoscopic hemostasis was achieved using 
standard hemoclips, over-the-scope clips (OTSC ® , Ovesco, 
Tübingen), loop ligation (endo loop, Olympus ® ) or argon plasma 
coagulation (APC, Erbe, Tübingen). In the absence of immediate 
hemorrhage, performed hemostatic interventions were consid-
ered prophylactic hemostasis.
 Adenoma size was measured on the histopathological speci-
men. In case of piecemeal resection, the size of the largest patho-
logical piece was recorded. After polypectomy, proton pump in-
hibitors were administered for at least 4 weeks. The majority of 
interventions were performed on an in-patient basis depending on 
the adenoma size, the difficulty of the procedure, and the comor-
bidities of the patient. 
 Follow-Up 
 The first follow-up endoscopy in case of complete resection was 
conducted 12 months after endoscopic polypectomy or at the dis-
cretion of the endoscopist. 
 Fig. 2.  a Endoscopic assessment of the location and size of the NAD.  b Submucosal saline injection in order to 
create a cushion.  c Snare polypectomy of the entire NAD.  d Prophylactic adaption of polypectomy site using he-
moclips. 
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 Statistical Analysis 
 The statistical analysis was focused on factors that predicted the 
occurrence of acute or delayed bleeding and the presence of ad-
vanced histopathology. Advanced histopathology was defined as the 
presence of tubulovillous changes and low or high-grade dysplasia. 
In 3 separate logistic regressions, acute bleeding, delayed bleeding, 
and advanced histopathology served as 3 separate outcome vari-
ables. Demographic characteristics (age, gender), polyp characteris-
tics (size, number, histopathology), resection technique (snare, bi-
opsy, RFA, piecemeal vs. en bloc resection, prophylactic measures 
of hemostasis), and clinical history (prior bleeding, anticoagulation 
treatment) all served as predictor variables. The results of the mul-
tivariate analyses were assessed in terms of significant odds ratios or 
 p values associated with individual predictor variables.
 Results 
 Patients 
 We here present a retrospective cohort of patients un-
dergoing EMR of histologically confirmed adenomas of 
the duodenum performed at our institution, the largest 
tertiary referral center in Switzerland. A total of 78 pa-
tients (47 male [60%] and 31 female [40%]) with NAD 
underwent endoscopic removal ( Table 1 ). The mean age 
of the population was 65.7 years. Eight out of the 78 ad-
enomas (10%) were associated with FAP, whereas 70 of 
the adenomas were sporadic (90%). 
 Adenoma Features 
 The mean adenoma size was 16.8 mm (range 2–55 mm). 
Sixty-two (79.5%) adenomas were solitary, whereas 16 
(20.5%) were multifocal. Histopathological evaluation re-
vealed 54 (69.2%) tubular and 24 (30.8%) tubulovillous 
adenomas. Sixty-five (83.3%) were graded as low grade 
and the remaining 13 (16.7%) as high grade dysplasia. 
 Endoscopic Resection Features 
 The majority ( n = 72, 92.3%) of the adenomas were 
hot snare resected after submucosal saline injection. The 
remaining 6 (7.7%) polypectomies of small adenomas 
were performed using a standard biopsy forceps ( Ta-
ble  2 ). In 35.9% (28) en bloc resection was possible, 
whereas the remaining 64.1% (50) of the lesions were re-
sected in a piecemeal technique. A mean of 1.2 (range 
1–6) procedures were necessary to achieve a primary ad-
enoma-free resection site in 91% (71) of patients. Six pa-
tients (7.7%) remain under regular observation includ-
ing repetitive endoscopic resection of remaining adeno-
matous tissue. In one patient (1.3%), after an initial 
attempt to endoscopically resect a multitude of polyps, a 
secondary surgical resection had to be performed due to 
incomplete endoscopic removal. In 49 (62.8%) of the cas-
es, prophylactic hemostasis using hemoclips ( n = 26, 
53.1%), APC ( n = 8, 16.3%), OTSC ® ( n = 6, 12.2%), loop 
ligation ( n = 1, 2%) or a combination of these ( n = 8, 
16.3%) was performed at the time of primary endoscop-
ic resection.
 Adverse Events 
 All of the 10 (12.8%, 7 minor, 3 major) intraprocedur-
al bleedings were stopped by endoscopic measures. In 
7  cases (9%), delayed bleeding (major 6, minor 1) was 
noticed after the primary intervention. Endoscopic he-
mostasis was then achieved in all cases. The mean time 
from the endoscopic adenoma resection to occurrence of 
delayed bleeding was 52 h (range 5–240 h). Of the patients 
with delayed bleeding, one patient underwent resection 
while still on a low-dose treatment with acetyl salicylic 
acid. A second patient had stopped the antiplatelet medi-
cation more than 7 days before the polypectomy. The re-
maining 5 patients did not take any anticoagulants. In 
4 out of these 7 patients with delayed bleeding, prophy-
lactic endoscopic hemostasis or hemostasis of a proce-
dural bleeding had already been performed (APC and or 
clip application).
 Two out of 78 (2.6%) patients had a duodenal perfora-
tion that was successfully closed using an OTSC ® .
 Risk Factors for Adverse Events 
 Acute post-polypectomy bleeding was statistically and 
significantly associated with large polyp size ( p = 0.003) 
and lack of endoscopic prophylaxis ( p = 0.0008). Delayed 
Table 1.  Patient and lesion characteristics
  n Range Percentage
Patients 78
Age, years, mean 65.9 33–91
Gender
Male 47 60.3
Female 31 39.7
Non-FAP 70 89.7
FAP 8 10.3
HNPCC 0 0.0
Adenomas
Size, mm, mean 17.2 2–55
Solitary 62 79.5
Multifocal 16 20.5
Histopathology, n
Tubular 54 69.2
Tubulo-villous 24 30.8
Dysplasic grading
LGD 65 83.3
HGD 13 16.7
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post-polypectomy bleeding showed a trend in large pol-
yps ( p = 0.064) and was statistically and significantly as-
sociated with familial cancer syndrome ( p = 0.019) and 
advanced histopathology ( p = 0.013). Lastly, advanced 
histopathology was statistically significantly associated 
with large polyp size. In general, age and gender did not 
affect bleeding or polyp type. 
 Follow-up 
 Endoscopic long-term (mean 33 months, range 1–121) 
follow-up was available in 68 patients. During follow-up, 
there was no recurrence of duodenal adenoma in any of 
the patients who achieved complete endoscopic resec-
tion.
 Three (3.8%) patients were lost to follow-up after ini-
tial polypectomy. Follow-up was not yet due at the time 
of data analysis in 7 patients (9%). Seven patients (9%) did 
not achieve a primary complete adenoma removal and 
were therefore under regular surveillance for a longer 
time with repetitive endoscopic resections going on 
( Fig. 1 ). 
 Review of the Literature 
 A PubMed search was performed using the following 
Mesh-Terms: duodenal adenoma; nonampullary duode-
nal adenoma; duodenal polyposis; endoscopic resection; 
endoscopic treatment. After review of the abstracts, 17 
publications were found to be clinically relevant and were 
then further analyzed ( Table 3 ). A total of 519 patients 
were included in the 17 cohorts. The mean population 
size was 38 patients (range 12–106) with a mean follow-
up of 26 months (range 0–100). 
 One of the first publications was presented by Apel et 
al. [6] in 2005. Using a classic EMR technique after sub-
mucosal saline injections, a total of 21 polypectomies 
were performed. The authors did not report any short-
term adverse events, whereas delayed bleeding occurred 
in 9.5% of the cases. Adenoma recurrence rate upon fol-
low-up was 25%. Three years later, Lepilliez et al. [8] pre-
sented another retrospective analysis of endoscopically 
resected nonampullary duodenal adenomas. Among 
their 35 patients, the procedural bleeding rate was 14%, 
while delayed bleeding occurred in 11.6%. After a mean 
follow-up of 15 months, no adenoma recurrence was not-
ed. Several other authors found an immediate bleeding 
rate in the same range (6–18%)  [3, 9–12] . In 2 studies, 
high rates of procedural hemorrhage (57.8 and 43%, re-
spectively) were observed  [13, 14] , whereas 3 authors did 
not observe any procedural bleeding complications  [2, 5, 
15] . Duodenal perforation occurred in 8 cases among all 
Table 2.  Endoscopic treatment and follow-up
Endoscopic treatment n Range Percentage
Snare 72 92.3
Biopsy 6 7.7
En bloc 28 35.9
Piecemeal 50 64.1
Amount of EMR, mean 1.2 1–6
Amount of EMR, median 1
End of treatment success
Yes 71 91.0
Ongoing 6 7.7
Surgery 1 1.3
Prophylactic endoscopic 
hemostasis
No 29 37.2
Yes 49 62.8
APC 9 18.4
Hemoclip 26 53.1
OTSC 6 12.2
Loop 1 2.0
Combination 8 16.3
Adverse events
Procedural bleeding
No 68 87.2
Minor 7 9.0
Major 3 3.8
Endoscopic hemostasis
APC 1 10.0
Hemoclip 5 50.0
OTSC 4 40.0
Delayed bleeding
No 71 91.0
Minor 1 1.3
Major 6 7.7
Mean time to bleeding, h 52
Endoscopic hemostasis
APC 1 14.3
Hemoclip 3 42.9
OTSC 2 28.6
Combination 1 14.3
Perforation
No 76 97.4
Yes 2 2.6
Treatment
OTSC 2 100.0
Follow-up
Incomplete initial resection 7 9.0
No follow-up yet 4 5.1
Lost to follow-up 3 3.8
Cases with a follow-up 64 82.1
Mean follow-up, months 33 2–112
Adenoma recurrence
No 64 100.0
Yes 0 0.0
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studies leading to an overall perforation of 1.5%  [8, 13, 
16–18] . Delayed bleeding was noted in 7.5–15% in those 
studies that evaluated delayed adverse events. The inci-
dence of adenoma recurrence showed substantial varia-
tion between 0 and 52% for a mean follow-up time of 23 
months (range 0–100).
 Discussion 
 Duodenal polyps are a relatively rare finding upon 
endoscopy in usually asymptomatic patients  [19–22] . 
They consist of duodenal adenomas, gastric metaplasia, 
or submucosal lesions such as lipoma or GISTs. Even 
though little is known about the tumor biology of duo-
denal adenomas, they are believed to follow an adeno-
ma-carcinoma sequence comparable to colonic adeno-
mas  [6] . Due to their malignant potential, duodenal ad-
enomas occurring sporadically or in familial polyposis 
syndromes should be removed. Compared to tubular 
adenomas, tubulovillous lesions bear an increased risk 
to undergo malignant transformation  [6] . In our cohort, 
approximately one third of the adenomas were tubulo-
villous. Historically, duodenal adenomas have been ap-
proached surgically, associated with substantial morbid-
ity and mortality and with elevated recurrence rates 
most likely due to incomplete resection. Today, the ap-
proach of choice in limited disease should be endoscop-
ic resection. Currently, there is only limited and mostly 
retrospective data available concerning the endoscopic 
removal of NAD. Despite the lack of large, prospective 
studies analyzing the efficacy and safety of endoscopic 
treatment of duodenal adenomas, the advantages such 
as accurate identification and visualization of complete 
resection, organ preservation, reduction of periopera-
tive risks, recovery, and length of hospital stay are evi-
dent. 
 A significant portion of the patients undergoing pol-
ypectomy of NAD at our tertiary-care center were refer-
rals from other gastroenterology centers. So far, we here 
present the largest cohort of NAD polypectomies in 
 Switzerland. 
 In our cohort, we found a fairly high rate of immedi-
ate bleeding (14%) compared to colonic polypectomy 
 [23, 24] with classic bleeding rates below 5%. This fact is 
most likely due to the abundant vascularization of the 
duodenal mucosa. The occurrence of acute post-polyp-
ectomy hemorrhage was statistically and significantly 
associated with large polyp size and the lack of endo-
scopic. Prophylactic hemostasis was performed in over 
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60% of our patients. Delayed bleeding occurred in al-
most 10% of the cases with a statistical trend in advanced 
adenoma histology and familial polyposis syndrome. In-
terestingly, no significant association was found be-
tween continued antithrombotic (low dose aspirin,  n = 
4) medication and hemorrhage. In our experience, dif-
fuse oozing was the predominant type of bleeding most 
likely due to the highly vascularized duodenal wall. Us-
ing standard through-the-scope clips seem less suitable 
for dealing with such bleeding. APC offers additional 
ablation of residual adenomatous tissues at the resection 
edges, yet bears the risk of transmural injury of the thin 
duodenal wall. The recently introduced OTSC ® now of-
fers an endoscopic tool for the compression of larger 
areas. Further studies need to assess which of the avail-
able tools for endoscopic hemostasis is the optimal one 
in case of duodenal polypectomy.
 The frequency of perforation in our cohort was com-
parably low with 2.6% (2/76). Both duodenal perforations 
among our patients were successfully closed immediately 
after resection using an OTSC ® and surgery was avoided. 
These findings underline an approximately 10-fold in-
creased perforation risk in the duodenum compared to 
the reported perforation rate of 0.07–0.13% in the ascend-
ing colon and the caecum  [24] .
 In our cohort, we were able to confirm that the most 
relevant adverse event of endoscopic duodenal adenoma 
resection despite prophylactic measures is immediate and 
delayed bleeding from the polypectomy site. Given this 
relatively high frequency of adverse events compared to 
colonic polypectomy, we suggest that endoscopic resec-
tion of NAD should be performed in centers with exper-
tise in the field.
 Compared to a fairly high adenoma recurrence rate in 
other cohorts, our data show that once a duodenal ade-
noma is removed in toto, the risk of recurrence is very low 
to absent in the long-term follow-up (mean 3 years). We 
therefore believe that this discrepancy in recurrence rates 
is more likely due to the initial incomplete resection rath-
er than adenoma recurrence. Yet, no consensus regarding 
surveillance intervals has been found among experts so 
far. To exhaustively address this question, larger cohorts 
are needed.
 In conclusion, given the high rates of successful com-
plete resection, our data support the opinion that spo-
radic and syndrome-associated NAD should be ap-
proached endoscopically. The most prevalent adverse 
event seems to be hemorrhage even in cases of prophylac-
tic hemostasis. Furthermore, our data show that adenoma 
recurrence is less frequent than previously suggested in 
case of primary R0 resection.
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